The implanted InterStim™ system electrically stimulates the sacral nerve which is thought to normalize neural communication between the bladder and brain1 and between the bowel and brain.2
InterStim Therapy for Urinary Control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.
InterStim Therapy for Bowel Control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.
The larger size of the InterStim neurostimulator over that of the InterStim II neurostimulator model 3058 allows for a larger battery with increased capacity. The InterStim neurostimulator is intended for patients who can accommodate a larger neurostimulator and will benefit from the use of a longer-lasting battery for their symptom control.
The InterStim neurostimulator:
The InterStim neurostimulator model 3023 uses a lead and an extension as part of the Sacral Neuromodulation system.
InterStim model 3023 with an eligible serial number has FDA-approved labeling for 1.5 Tesla MRI head scans.
Refer to the MRI Guidelines for a complete list of conditions and instructions for use (available on the Medtronic Manuals Library).
Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (InterStim) or model number (3023). You may also call 800-961-9055 for a copy of a manual.
|Weight||42 g (1.5 oz)|
|Height||55 mm (2.2 in)|
|Length||60 mm (2.4 in)|
While the precise mechanism of action of SNM has not been fully established, efficacy has been proven in clinical studies.
Johnson M. Transcutaneous electrical nerve stimulation (TENS). Published online Oct 15, 2012.
Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100:959–968.